The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 1292-1302.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, C.-H.
Right arrow Articles by Chen, Y.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, C.-H.
Right arrow Articles by Chen, Y.-F.

Leptin-Induced IL-6 Production Is Mediated by Leptin Receptor, Insulin Receptor Substrate-1, Phosphatidylinositol 3-Kinase, Akt, NF-{kappa}B, and p300 Pathway in Microglia1

Chih-Hsin Tang2,*, Da-Yuu Lu2,{ddagger}, Rong-Sen Yang2,§, Huei-Yann Tsai*, Ming-Ching Kao{dagger}, Wen-Mei Fu3,{ddagger} and Yuh-Fung Chen3,*

* Department of Pharmacology, {dagger} Graduate Institute of Medical Science, College of Medicine, China Medical University, Taichung, Taiwan; and {ddagger} Department of Pharmacology and § Department of Orthopaedics, College of Medicine, National Taiwan University, Taipei, Taiwan

Leptin, the adipocyte-secreted hormone that centrally regulates weight control, is known to function as an immunomodulatory regulator. We investigated the signaling pathway involved in IL-6 production caused by leptin in microglia. Microglia expressed the long (OBRl) and short (OBRs) isoforms of the leptin receptor. Leptin caused concentration- and time-dependent increases in IL-6 production. Leptin-mediated IL-6 production was attenuated by OBRl receptor antisense oligonucleotide, PI3K inhibitor (Ly294002 and wortmannin), Akt inhibitor (1L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), NF-{kappa}B inhibitor (pyrrolidine dithiocarbamate), I{kappa}B protease inhibitor (L-1-tosylamido-2-phenylenylethyl chloromethyl ketone), I{kappa}B{alpha} phosphorylation inhibitor (Bay 117082), or NF-{kappa}B inhibitor peptide. Transfection with insulin receptor substrate (IRS)-1 small-interference RNA or the dominant-negative mutant of p85 and Akt also inhibited the potentiating action of leptin. Stimulation of microglia with leptin activated I{kappa}B kinase {alpha}/I{kappa}B kinase beta, I{kappa}B{alpha} phosphorylation, I{kappa}B{alpha} degradation, p65 phosphorylation at Ser276, p65 and p50 translocation from the cytosol to the nucleus, and {kappa}B-luciferase activity. Leptin-mediated an increase of I{kappa}B kinase {alpha}/I{kappa}B kinase beta activity, {kappa}B-luciferase activity, and p65 and p50 binding to the NF-{kappa}B element was inhibited by wortmannin, Akt inhibitor, and IRS-1 small-interference RNA. The binding of p65 and p50 to the NF-{kappa}B elements, as well as the recruitment of p300 and the enhancement of histone H3 and H4 acetylation on the IL-6 promoter was enhanced by leptin. Our results suggest that leptin increased IL-6 production in microglia via the leptin receptor/IRS-1/PI3K/Akt/NF-{kappa}B and p300 signaling pathway.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Science Council of Taiwan (NSC 95-2314-B-039-045) and China Medical University (CMU 95-208).

2 C.-H.T., D.-Y.L., and R.-S.Y. contributed equally to this study.

3 Address correspondence and reprint requests to Dr. Chen Yuh-Fung, Department of Pharmacology, College of Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung, Taiwan; E-mail address: yfchen{at}mail.cmu.edu.tw or Dr. Fu Wen-Mei, Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan; E-mail address: wenmei{at}ntu.edu.tw

4 Abbreviations used in this paper: OBR, lectin receptor; IRS-1, insulin receptor substrate-1; IKK, I{kappa}B kinase; siRNA, small-interference RNA; ODN, oligonucleotide; DAPA, DNA affinity protein-binding assay; ChIP, chromatin immunoprecipitation; AS, antisense; MM, missense; PDTC, pyrrolidine dithiocarbamate; TPCK, L-1-tosylamido-2-phenylenylethyl chloromethyl ketone.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
C.-H. Tang, J.-Y. Chuang, Y.-C. Fong, M.-C. Maa, T.-D. Way, and C.-H. Hung
Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-{kappa}B pathways and promotes osteoclastogenesis in human oral cancer cells
Carcinogenesis, August 1, 2008; 29(8): 1483 - 1492.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Nishida, A. Andoh, M. Shioya, S. Kim-Mitsuyama, A. Takayanagi, and Y. Fujiyama
Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32{alpha} induction in human pancreatic periacinar myofibroblasts
Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G831 - G838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.